Ventilator associated Pneumonia (VAP) The AMR Narrative The Challenge. The Evidence. The Solution. Ventilator Associated Pneumonia (VAP) remains a serious clinical issue in UK ICUs with NHS England data estimating 3,0006,000 deaths per year and treatment costs of 10,00020,000 Hospital acquired pneumonia (HAP) and ventilator associated pneumonia (VAP) are prevalent healthcare associated infections worldwide, with varying rates across countries. The emergence of Pfizer Medical How effective are oral hygiene measures for preventing pneumonia in critically ill people on ventilators? Cochrane Oral Health Greater collaboration between ICU nurses and ICU physicians may minimize VAP risk